Earnings Alerts

Hologic Inc (HOLX) Earnings: Prelim 1Q Revenue Hits $1.02B, Meeting Estimates

By January 13, 2025 No Comments
  • Hologic’s preliminary Q1 revenue is $1.02 billion.
  • This figure aligns with the company’s earlier estimate of approximately $1.02 billion.
  • CFO Karleen Oberton noted that revenue was impacted by a $9 million reduction due to the strengthening U.S. dollar.
  • Despite currency challenges, Hologic expects both GAAP and non-GAAP earnings per share to approach the high end of its guidance ranges.
  • Market analyst ratings include 9 buy recommendations, 12 hold ratings, and 1 sell rating.

Hologic Inc on Smartkarma



Analyst coverage of Hologic Inc on Smartkarma has been positive, with analysts from Baptista Research providing insightful reports on the company. In a report titled “Hologic Inc.: Expanding Diagnostic Assay Portfolio For A Competitive Edge! – Major Drivers”, the analysts highlighted the company’s recent financial results for the fourth quarter and fiscal year 2024. Hologic saw a 4.2% increase in total revenue in the fourth quarter, reaching $987.9 million. Organic revenue growth, excluding COVID-related sales, was at 5%, and non-GAAP earnings per share grew by 13.5% to $1.01, indicating strength and resilience in the company’s performance.

In another report by Baptista Research titled “Hologic Inc.: Breast Health Innovations”, the analysts commended Hologic for its strong performance in the third quarter of fiscal 2024. The company showed resilience and strategic efficiency in navigating post-pandemic market conditions, reporting total revenue of $1.01 billion and a non-GAAP earnings per share of $1.06. This exceeded their guidance predictions and marked a return to revenue growth with a 3.1% increase compared to the previous year. The analysts noted this as a positive signal of Hologic’s recovery trajectory after the challenges posed by COVID-19 and global disruptions, such as the chip shortage.



A look at Hologic Inc Smart Scores

FactorScoreMagnitude
Value3
Dividend1
Growth3
Resilience3
Momentum3
OVERALL SMART SCORE2.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Hologic Inc has an overall positive outlook for the long term. With solid scores in Value, Growth, Resilience, and Momentum, the company is positioned well for future success. Hologic Inc is known for its premium diagnostic products, medical imaging systems, and surgical products, with core business units in diagnostics, breast health, GYN surgical, and skeletal health.

While the Dividend score is lower, the strengths in other areas indicate strong potential for growth and resilience in the market. Investors looking for a company with a well-rounded profile and focus on key healthcare sectors may find Hologic Inc to be a promising choice for long-term investment.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars